Trial Profile
Features of responders to Tolvaptan in CKD patients
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 19 Sep 2016
Price :
$35
*
At a glance
- Drugs Tolvaptan (Primary)
- Indications Kidney disorders
- Focus Therapeutic Use
- Acronyms CKD-FORT
- 08 Sep 2016 Status changed from recruiting to discontinued.
- 20 Mar 2014 New trial record